Maytansine.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004064:Digestive System / Q000187:drug effects; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008453:Maytansine / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D009420:Nervous System / Q000187:drug effects; D010078:Oxazines / Q000494:pharmacology*; D011247:Pregnancy; D013723:Teratogens
D010078:Oxazines; D013723:Teratogens; D008453:Maytansine